255 related articles for article (PubMed ID: 15325479)
21. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.
Michałek M; Tabiś A; Pasławska U; Noszczyk-Nowak A
BMC Vet Res; 2020 Jan; 16(1):26. PubMed ID: 32000761
[TBL] [Abstract][Full Text] [Related]
22. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy.
Cesta MF; Baty CJ; Keene BW; Smoak IW; Malarkey DE
Vet Pathol; 2005 Jul; 42(4):458-67. PubMed ID: 16006605
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cardiomyopathy in a litter of five mixed-breed cats.
Kraus MS; Calvert CA; Jacobs GJ
J Am Anim Hosp Assoc; 1999; 35(4):293-6. PubMed ID: 10416772
[TBL] [Abstract][Full Text] [Related]
24. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.
Rush JE; Freeman LM; Brown DJ; Smith FW
J Am Anim Hosp Assoc; 1998; 34(1):38-41. PubMed ID: 9527429
[TBL] [Abstract][Full Text] [Related]
25. ECG of the month. Hypertrophic cardiomyopathy.
Bruskiewicz KA; Rubin SI
J Am Vet Med Assoc; 1995 Mar; 206(5):623-4. PubMed ID: 7744680
[No Abstract] [Full Text] [Related]
26. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
Fox PR; Keene BW; Lamb K; Schober KA; Chetboul V; Luis Fuentes V; Wess G; Payne JR; Hogan DF; Motsinger-Reif A; Häggström J; Trehiou-Sechi E; Fine-Ferreira DM; Nakamura RK; Lee PM; Singh MK; Ware WA; Abbott JA; Culshaw G; Riesen S; Borgarelli M; Lesser MB; Van Israël N; Côté E; Rush JE; Bulmer B; Santilli RA; Vollmar AC; Bossbaly MJ; Quick N; Bussadori C; Bright JM; Estrada AH; Ohad DG; Fernández-Del Palacio MJ; Lunney Brayley J; Schwartz DS; Bové CM; Gordon SG; Jung SW; Brambilla P; Moïse NS; Stauthammer CD; Stepien RL; Quintavalla C; Amberger C; Manczur F; Hung YW; Lobetti R; De Swarte M; Tamborini A; Mooney CT; Oyama MA; Komolov A; Fujii Y; Pariaut R; Uechi M; Tachika Ohara VY
J Vet Intern Med; 2018 May; 32(3):930-943. PubMed ID: 29660848
[TBL] [Abstract][Full Text] [Related]
27. Is treatment of feline hypertrophic cardiomyopathy based in science or faith? A survey of cardiologists and a literature search.
Rishniw M; Pion PD
J Feline Med Surg; 2011 Jul; 13(7):487-97. PubMed ID: 21704898
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.
Hori Y; Iguchi M; Heishima Y; Yamashita Y; Nakamura K; Hirakawa A; Kitade A; Ibaragi T; Katagi M; Sawada T; Yuki M; Kanno N; Inaba H; Isayama N; Onodera H; Iwasa N; Kino M; Narukawa M; Uchida S
J Vet Intern Med; 2018 May; 32(3):922-929. PubMed ID: 29660794
[TBL] [Abstract][Full Text] [Related]
29. Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy.
Yang VK; Freeman LM; Rush JE
Am J Vet Res; 2008 Aug; 69(8):1061-6. PubMed ID: 18672971
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic cardiomyopathy in man and cats.
Maron BJ; Fox PR
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S6-9. PubMed ID: 26776595
[TBL] [Abstract][Full Text] [Related]
31. Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy.
Payne JR; Borgeat K; Brodbelt DC; Connolly DJ; Luis Fuentes V
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S318-28. PubMed ID: 26776589
[TBL] [Abstract][Full Text] [Related]
32. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
Reina-Doreste Y; Stern JA; Keene BW; Tou SP; Atkins CE; DeFrancesco TC; Ames MK; Hodge TE; Meurs KM
J Am Vet Med Assoc; 2014 Sep; 245(5):534-9. PubMed ID: 25148095
[TBL] [Abstract][Full Text] [Related]
33. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999).
Rush JE; Freeman LM; Fenollosa NK; Brown DJ
J Am Vet Med Assoc; 2002 Jan; 220(2):202-7. PubMed ID: 12126131
[TBL] [Abstract][Full Text] [Related]
34. Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
Coleman AE; DeFrancesco TC; Griffiths EH; Lascelles BDX; Kleisch DJ; Atkins CE; Keene BW
J Vet Cardiol; 2020 Aug; 30():77-91. PubMed ID: 32707333
[TBL] [Abstract][Full Text] [Related]
35. Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005).
Payne J; Luis Fuentes V; Boswood A; Connolly D; Koffas H; Brodbelt D
J Small Anim Pract; 2010 Oct; 51(10):540-7. PubMed ID: 21029098
[TBL] [Abstract][Full Text] [Related]
36. Association of the myosin binding protein C3 mutation (MYBPC3 R820W) with cardiac death in a survey of 236 Ragdoll cats.
Borgeat K; Casamian-Sorrosal D; Helps C; Luis Fuentes V; Connolly DJ
J Vet Cardiol; 2014 Jun; 16(2):73-80. PubMed ID: 24906243
[TBL] [Abstract][Full Text] [Related]
37. Management of asymptomatic (occult) feline cardiomyopathy: Challenges and realities.
Fox PR; Schober KA
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S150-8. PubMed ID: 26776574
[TBL] [Abstract][Full Text] [Related]
38. Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.
Yang VK; Rush JE; Bhasin S; Wagers AJ; Lee RT
J Vet Cardiol; 2019 Oct; 25():41-51. PubMed ID: 31568985
[TBL] [Abstract][Full Text] [Related]
39. Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study).
Payne JR; Brodbelt DC; Luis Fuentes V
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S244-57. PubMed ID: 26776583
[TBL] [Abstract][Full Text] [Related]
40. Genetic basis of hypertrophic cardiomyopathy.
Lind JM; Chiu C; Semsarian C
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
